 |
Oded Langer, MD, PhD
|
Chairman and Professor, Department of Obstetrics and Gynecology |
| For Insurance Providers, please call the physician's office |
| Board Certification |
Obstetrics and Gynecology |
| Education |
- 1967 BS, Hebrew University, Jerusalem, Israel
- 1968 Education Certificate, Hebrew University
- 1973 MD, Sackler Medical School, Tel Aviv University
- 2004 PhD, Poznan University of Medical Sciences, Posnan, Poland
- 1973-1979 Ob/Gyn Residency, Meir General Hospital, Sackler Medical School, Tel Aviv University
- 1980-1981 Obstetrics and Gynecology Registrar, University of Witwatersrand Medical School, Johannesburg, South Africa
- 1984-1986 Fellow, Maternal-Fetal Medicine, Albert Einstein College of Medicine (AECOM), Bronx, NY
|
| Academic Appointments |
F. Huntington and Dorothy D. Babcock Professor of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons |
| Special Interests or Skills |
- Diabetes in pregnancy
- Medical complications of pregnancy
- Labor and delivery
|
Dr. Oded Langer is Babcock Professor of Obstetrics and Gynecology at Columbia University, and Chairman of the Department of Obstetrics and Gynecology at St. Luke’s-Roosevelt Hospital Center. He is a nationally and internationally-recognized expert in the treatment of diabetes in pregnancy; most recently, he has made significant contributions regarding the safe and effective use of oral medications for diabetes during pregnancy.
Dr. Langer completed a Bachelor of Science degree from Hebrew University, Jerusalem; he also holds an M.D. degree from Sackler School of Medicine, Tel Aviv University, and a Ph.D. degree from the Poznan University of Medical Sciences in Poznan, Poland. He completed his obstetrics and gynecology residency at Sackler School of Medicine. Following residency, he spent two years in obstetrics and gynecology in Johannesburg, South Africa. He then completed a fellowship in maternal-fetal medicine at Albert Einstein College of Medicine in New York where he served as Associate Professor and Director of Obstetrics and Perinatology from 1984-1989 and was concurrently co-investigator and director of the diabetes in pregnancy unit of the DRTC. Thereafter, he assumed the Blumberg Professorship, Director of Obstetrics and Maternal-Fetal Medicine, and Deputy Chairman of the Department of Obstetrics and Gynecology at the University of Texas Health Science Center at San Antonio. Dr. Langer assumed his current position at St. Luke’s-Roosevelt Hospital Center in December, 1999.
In the course of his career, Dr. Langer has served as principal or co-investigator on several NIH and pharmaceutical studies, and has repeatedly received the Award of Research Excellence from the Society of Maternal-Fetal Medicine. In 2005, in recognition of his leadership in the field of maternal/fetal toxicology, Dr. Langer was the invited recipient of the Andre Boivin Visiting Professorship at the Motherisk Program, Hospital for Sick Children, Toronto; also that year, in recognition for his outstanding contributions to diabetes in pregnancy, he was honored with the Donnell D. Etzwiler Professorship; and in 2003, for outstanding contributions to the field of diabetes and pregnancy, he was invited presenter of the Norbert Freikel Lecture for the American Diabetes Association. Dr. Langer has served as chairman of several medical and scientific research groups and postgraduate courses, and was formally and repeatedly recognized as "teacher of the year" for residents’ instruction at both Albert Einstein College of Medicine and the University of Texas Health Science Center at San Antonio.
Dr. Langer has contributed extensively to the literature in obstetrics and gynecology through publications in both journals and textbooks, and is co-editor of two textbooks on diabetes and pregnancy. He has served on a variety of journal editorial boards in the field. He has a longtime interest in high-risk pregnancy, particularly diabetes in pregnancy. His contributions include advances in the use of oral agents for treatment of diabetes in pregnancy, in understanding and treating the complications of diabetes to mother and fetus, diagnosis criteria and assessment, and the association between level of glycemia and pregnancy outcome. He served as the chairman of the Diabetes in Pregnancy Interest Group of the Society of Maternal-Fetal Medicine and is a founding member of the Diabetes in Pregnancy Study Group of North America.
|
|
